{"schema_version":"alpha-profile-public-v1","slug":"george-mclean-milne-jr-ph-d","canonical_url":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d","as_of":"2026-09-16T16:50:44.750259+00:00","published_at":"2026-09-02T02:37:19.763212+00:00","last_reviewed_at":"2026-05-15T22:42:33.148+00:00","identity":{"display_name":"George Mclean Milne Jr., Ph.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":{"company_name":"Amylyx Pharmaceuticals, Inc.","company_slug":"amylyx-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"AMLX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2015-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=george-mclean-milne-jr-ph-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=george-mclean-milne-jr-ph-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Verdine is one of Wave's founders and has served as a director since July 2013, previously serving as President, CEO and CSO. He is the Erving Professor of Chemistry, Emeritus at Harvard University and has co-founded numerous biopharmaceutical companies."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Amylyx Pharmaceuticals, Inc.","organizationId":"amylyx-pharmaceuticals-inc","title":"Director","period":"2015-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Amylyx Pharmaceuticals, Inc.","company_slug":"amylyx-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"AMLX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2015-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"}}],"claims":[{"claim_type":"ai_expertise","claim_value":{"detail":"HR executive with experience at Novartis and Shire, and former consultant at Booz Allen Hamilton in organization change and effectiveness.","ai_expertise":true},"claim_text":"SEC-derived executive row classified AI expertise as True.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:31.526725+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.577404+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_governance_relevance","claim_value":{"reasons":["sec_derived_ai_expertise_signal"],"relevant":true},"claim_text":"AI-governance relevance classified as True from role/title and SEC-derived executive context.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:31.526725+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.577404+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for George Mclean Milne Jr., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T17:40:08.396726+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMLX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T17:40:08.139297+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Gregory L. Verdine, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T03:09:13.13339+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"WVE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","published_at":"2025-06-23T00:00:00+00:00","last_checked_at":"2026-05-05T03:09:12.976957+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"AMLX","role_type":"Chair","organization":"Amylyx Pharmaceuticals, Inc."},"claim_text":"Serves on the board of Amylyx Pharmaceuticals, Inc. as Chair.","claim_state":"verified","valid_from":"2015-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:39.662574+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Amylyx Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.05354+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"George Mclean Milne Jr., Ph.D. currently serves as Chair at Amylyx Pharmaceuticals, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T17:40:08.311075+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMLX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T17:40:08.139297+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation","Nominating/Governance","Science/Innovation"],"claim_text":"George Mclean Milne Jr., Ph.D. serves on Audit, Compensation, Nominating/Governance, Science/Innovation.","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T17:40:08.361733+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMLX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T17:40:08.139297+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":{"committees":["Audit","Compensation","Nominating/Governance"]},"claim_text":"Committee assignments at Amylyx Pharmaceuticals, Inc.: Audit, Compensation, Nominating/Governance.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:39.662574+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Amylyx Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.05354+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for George Mclean Milne Jr., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T17:40:08.465671+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMLX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T17:40:08.139297+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Gregory L. Verdine, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T03:09:13.187405+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"WVE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","published_at":"2025-06-23T00:00:00+00:00","last_checked_at":"2026-05-05T03:09:12.976957+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2015},"claim_text":"Director tenure at Amylyx Pharmaceuticals, Inc. begins from 2015.","claim_state":"verified","valid_from":"2015-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:39.662574+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Amylyx Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.05354+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Nuvation Bio Inc.","claim_text":"Gary Hattersley, Ph.D. is associated with Nuvation Bio Inc..","claim_state":"verified","valid_from":"2026-04-10","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:04:08.961692+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1811063/000114036126014157/nuvb-20260521.htm","published_at":"2026-04-10T00:00:00+00:00","last_checked_at":"2026-05-05T00:04:08.783524+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"OMEROS CORP","claim_text":"George A. Gaitanaris, M.D., Ph.D. is associated with OMEROS CORP.","claim_state":"verified","valid_from":"2026-03-31","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:16:40.18582+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OMER 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-05T00:16:40.029549+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Biogen Inc.","claim_text":"Ginger Gregory, Ph.D. is associated with Biogen Inc..","claim_state":"verified","valid_from":"2026-02-06","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-29T08:20:19.023069+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm","published_at":"2026-02-06T00:00:00+00:00","last_checked_at":"2026-04-29T08:20:18.89039+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Wave Life Sciences Ltd.","claim_text":"Gregory L. Verdine, Ph.D. is associated with Wave Life Sciences Ltd..","claim_state":"verified","valid_from":"2025-06-23","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T03:09:13.115101+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"WVE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","published_at":"2025-06-23T00:00:00+00:00","last_checked_at":"2026-05-05T03:09:12.976957+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":{"ticker":"BIIB","company":"Biogen Inc."},"claim_text":"Ginger Gregory, Ph.D. is associated with Biogen Inc..","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:31.526725+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.577404+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_function","claim_value":{"role_family":"people_talent","role_type_normalized":"chro"},"claim_text":"Ginger Gregory, Ph.D. maps to the people talent executive function.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:31.526725+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.577404+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Scientific Officer","claim_text":"Gary Hattersley, Ph.D. is listed as Chief Scientific Officer at Nuvation Bio Inc..","claim_state":"verified","valid_from":"2026-04-10","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:04:08.939044+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1811063/000114036126014157/nuvb-20260521.htm","published_at":"2026-04-10T00:00:00+00:00","last_checked_at":"2026-05-05T00:04:08.783524+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Vice President, Science and Chief Scientific Officer","claim_text":"George A. Gaitanaris, M.D., Ph.D. is listed as Vice President, Science and Chief Scientific Officer at OMEROS CORP.","claim_state":"verified","valid_from":"2026-03-31","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:16:40.162845+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OMER 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm","published_at":"2026-03-31T00:00:00+00:00","last_checked_at":"2026-05-05T00:16:40.029549+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Executive Vice President and Chief Human Resources Officer","claim_text":"Ginger Gregory, Ph.D. is listed as Executive Vice President and Chief Human Resources Officer at Biogen Inc..","claim_state":"verified","valid_from":"2026-02-06","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-29T08:20:19.003684+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm","published_at":"2026-02-06T00:00:00+00:00","last_checked_at":"2026-04-29T08:20:18.89039+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Director","claim_text":"Gregory L. Verdine, Ph.D. is listed as Director at Wave Life Sciences Ltd..","claim_state":"verified","valid_from":"2025-06-23","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T03:09:13.094536+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"WVE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","published_at":"2025-06-23T00:00:00+00:00","last_checked_at":"2026-05-05T03:09:12.976957+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":{"title":"Executive Vice President and Chief Human Resources Officer","role_type_normalized":"chro"},"claim_text":"Ginger Gregory, Ph.D. is listed as Executive Vice President and Chief Human Resources Officer at Biogen Inc..","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:31.526725+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BIIB executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.577404+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":true},"claim_text":"Board independence status at Amylyx Pharmaceuticals, Inc.: True.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:39.662574+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Amylyx Pharmaceuticals, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.05354+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"President and Chief Executive Officer","company":"LifeMine Therapeutics Inc."},"claim_text":"Gregory L. Verdine, Ph.D. is also linked to LifeMine Therapeutics Inc. as President and Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T03:09:13.229531+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"WVE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","published_at":"2025-06-23T00:00:00+00:00","last_checked_at":"2026-05-05T03:09:12.976957+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for George Mclean Milne Jr., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T17:40:08.433532+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMLX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T17:40:08.139297+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Gregory L. Verdine, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T03:09:13.151606+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"WVE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","published_at":"2025-06-23T00:00:00+00:00","last_checked_at":"2026-05-05T03:09:12.976957+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:george-mclean-milne-jr-ph-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2015-01-01 · current","organization":"Amylyx Pharmaceuticals, Inc.","organization_id":"amylyx-pharmaceuticals-inc"},"claim_text":"Director at Amylyx Pharmaceuticals, Inc. (2015-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d#profile","url":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d","dateModified":"2026-05-15T22:42:33.148+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d#person","name":"George Mclean Milne Jr., Ph.D.","url":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Amylyx Pharmaceuticals, Inc.","tickerSymbol":"NASDAQ: AMLX"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2015-01-01","memberOf":{"@type":"Organization","name":"Amylyx Pharmaceuticals, Inc.","url":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc","tickerSymbol":"NASDAQ: AMLX"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","name":"AMLX DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525144678/d907905ddef14a.htm","name":"WVE DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1811063/000114036126014157/nuvb-20260521.htm","name":"NUVB DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm","name":"OMER 10-K executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm","name":"BIIB 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":15,"corroborated":6,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":21,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":9,"distinct_source_count":6,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":15,"corroborated":6,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":21,"corroborated_claims":6,"sources":9,"distinct_sources":6,"role_claims":1,"last_reviewed_at":"2026-05-15T22:42:33.148+00:00","observed_at":"2026-09-16T16:50:44.750259+00:00","freshness_days":124}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"george-mclean-milne-jr-ph-d","canonical_url":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d"},"publication":{"published_at":"2026-09-02T02:37:19.763212+00:00","last_reviewed_at":"2026-05-15T22:42:33.148+00:00","as_of":"2026-09-16T16:50:44.750259+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/george-mclean-milne-jr-ph-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}